Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Eric Lutz, Ph.D. is Sr. Principal Scientist at WindMIL Therapeutics. Eric has been involved in Tumor Immunotherapy-focused research for the past 18 years. He received a Ph.D. in Immunology from the Johns Hopkins School of Medicine and completed a Postdoctoral Fellowship in Tumor Immunology in also at Johns Hopkins. Prior to joining WindMIL in July 2016, Eric was a Research Assistant Professor in the Johns Hopkins Gastrointestinal Oncology Division, focusing on the development of immunotherapy for pancreatic cancer. Currently, he leads WindMIL Therapeutics’ research group focused on developing a novel form of adoptive cellular therapy named Marrow-infiltrating Lymphocytes (MILs) for the treatment of both solid and hematologic malignancies.